Clinical intelligence

The signs come early.

Chroneme connects them. Follow the findings across visits, test results, and messages. Each case shows what the care team sees and why it changes the next step.

Inspect the source records Read the ChronicleChronicle

Illustrative case · 01 / 12

Changing blood sugar

Clinic note01

Age 64No prior diabetes recorded

Lab resultsHbA1c · %

5.66.57.4

EarlierLatest

New diabetes pattern

A1c rises as weight falls

Possible pancreatic disease

Next step

Consider pancreatic imaging

01 / 04Baseline

Establish the patient’s baseline.

Linked sources

Age 64
02 · Lab results
03 · Home scale
04 · Patient message

Fig. 01 / Patient timeline END-PAC · Sharma et al., 2018

Review the sources · 12

Changing blood sugar
HbA1c 5.6% → 6.5% → 7.4%
At age 64, rising A1c, weight loss and back pain together raise concern for pancreatic disease. The clinician considers pancreatic imaging to investigate this pattern.
END-PAC · Sharma et al., 2018
Thyroid changes during cancer treatment
TSH 2.1 mIU/L → 9.8 mIU/L
Fatigue and feeling cold accompany the rise during checkpoint inhibitor treatment. The clinician requests a thyroid panel and alerts oncology to assess a possible treatment-related thyroid disorder.
ASCO · Schneider et al., 2021
Low bicarbonate during illness
HCO₃⁻ 14 mmol/L
Poor intake during an illness raises concern for ketoacidosis on this medication. The clinician considers urgent ketone testing because ketoacidosis can occur even with normal glucose.
Peters et al., 2015
Muscle symptoms after an antibiotic
CK 4,200 U/L
Leg pain and dark urine raise concern for muscle injury from the drug interaction. The clinician urgently reviews holding simvastatin and checks kidney function because severe muscle injury can damage the kidneys.
Patel et al., 2013
A change during cancer follow-up
CEA 2.0 ng/mL → 2.6 ng/mL → 3.4 ng/mL
A 5% weight loss, fatigue and right upper abdominal pain add concern for recurrence. The clinician considers bringing the May CT of the chest, abdomen and pelvis forward for prompt assessment.
ASCO · Meyerhardt et al., 2013
A gap in a diuretic refill
Δ +2 kg
The pharmacy shows a refill gap, and the cardiology visit was missed. The clinician calls to review symptoms and medication access before considering a higher diuretic dose.
OPTIMIZE-HF · Fonarow et al., 2008
Bleeding after a new antibiotic
INR 2.4 → 4.1
Bleeding gums alongside the higher INR raise concern for excessive anticoagulation. The higher INR and new bleeding prompt the clinician to assess severity, consider holding warfarin and recheck INR.
Fischer et al., 2010
Falling hemoglobin and black stools
Hb 13.2 g/dL → 11.4 g/dL → 9.8 g/dL
Black stools and dizziness accompany a 3.4 g/dL drop during NSAID use. Possible gastrointestinal bleeding prompts urgent clinical assessment and gastroenterology review.
ACG · Laine et al., 2021
Fever and rash during a local outbreak
T 39.4 °C
A rash spreading down from the face adds concern for measles. The clinician arranges isolation before arrival, testing and prompt notification of public health.
CDC · Clinical Overview of Measles, 2026
A genetic check before allopurinol
UA 7.6 mg/dL → 8.5 mg/dL → 9.4 mg/dL
Allopurinol 100 mg is ordered, and there is no HLA-B*58:01 result. The clinician considers HLA-B*58:01 testing before treatment because this variant raises the risk of a severe reaction.
ACR · FitzGerald et al., 2020
Checking a lab result
K⁺ 4.3 mmol/L → 6.1 mmol/L
Hemolysis can raise the measured potassium. The ECG shows no peaked T waves. The clinician assesses the patient and considers testing a fresh sample to clarify whether the potassium is truly elevated.
Meng & Wagar, 2015
Coronary calcium on a chest CT
LDL-C 148 mg/dL → 155 mg/dL → 162 mg/dL
The imaging finding and rising LDL merit review, and no statin appears in the record. The clinician reviews cardiovascular risk and discusses statin therapy with the patient.
AHA/ACC · Grundy et al., 2019